Clinical trials
Phase 3 Schizophrenia trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2007 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen-Cilag International NV | 3 |
| Boehringer Ingelheim | 2 |
| Bjorn H. Ebdrup | 1 |
| European Group for Research In Schizophrenia | 1 |
| Janssen-Cilag Ltd. | 1 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
| Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 1 |
| Neurocom | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 13 |
| Psychotic Disorders | 3 |
| Metabolic Syndrome | 2 |
| Cognitive Dysfunction | 1 |
| Obesity | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.